NDC11 00088250200
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00088-2502-0 | 00088-2502 |
| 00088-2502-00 | 00088-2502 |
| 0088-2502-00 | 0088-2502 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Apidra | INSULIN GLULISINE | sanofi-aventis U.S. LLC | e7af6a7a-8046-4fb4-9979-4ec4230b23aa | 2025-11-25 | Warnings, Adverse reactions | 0088-2502-00 0088-2502 00088250200 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.